India is often called the "Pharmacy of the World," supplying affordable generic medicines to over 200 countries. But how does the country's drug regulator ensure those medicines meet quality standards?…
The Central Drugs Standard Control Organization (CDSCO) is advancing a smarter, risk-based regulatory framework aimed at simplifying compliance for Indian pharmaceutical manufacturers while strengthening drug safety oversight. The initiative was…
The World Health Organization's Good Manufacturing Practice (WHO-GMP) certification is one of the most important — and most misunderstood — quality signals for anyone buying Indian generic medicines. This guide…
The Indian government has confirmed that Rs 5,210 crore (approximately $625 million) has been invested under the Production Linked Incentive (PLI) scheme for Key Starting Materials (KSM), drug intermediates, and…